Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mid-Bronx Endoscopy Center
AddedFeb 18, 2024
UpdatedJun 18, 2026
Mid-Bronx Endoscopy Center

Mid-Bronx Endoscopy Center

Pre-Seed

Mid-Bronx Endoscopy Center: A New York-based healthcare provider specializing in endoscopy since 2014.

HQ
Bronx River Houses, NY, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded in 2014, Mid-Bronx Endoscopy Center is a healthcare provider based in Bronx, New York, specializing in gastroenterology, hepatology, and gastrointestinal endoscopy. The center's core mission is to deliver high-quality specialty care through diagnostic and therapeutic upper and lower endoscopic procedures, including colorectal cancer prevention and hemorrhoid treatment. As a state-licensed and Joint Commission accredited outpatient ambulatory surgical facility, it aims to provide compassionate medicine where patients feel reassured and understood.

Notable for its commitment to quality and patient-centered care, Mid-Bronx Endoscopy Center has achieved significant milestones in healthcare service delivery. The accreditation by the Joint Commission underscores its adherence to rigorous healthcare standards. The center's impact is evident in its contribution to colorectal cancer prevention and the overall improvement of gastrointestinal health within the Bronx community. Through its specialized services, the center has become a trusted name in endoscopic healthcare.

Mid-Bronx Endoscopy Center - Quick Facts

When was Mid-Bronx Endoscopy Center founded?

Mid-Bronx Endoscopy Center was founded in 2014.

Where is Mid-Bronx Endoscopy Center's headquarters located?

Mid-Bronx Endoscopy Center's headquarters is located in Bronx River Houses, NY, US.

When was Mid-Bronx Endoscopy Center's last funding round?

Mid-Bronx Endoscopy Center's most recent funding round was for $835k (USD) in May 2015.

How much has Mid-Bronx Endoscopy Center raised to-date?

As of May 22, 2015, Mid-Bronx Endoscopy Center has raised a total of $835k (USD).

How many employees does Mid-Bronx Endoscopy Center have?

Mid-Bronx Endoscopy Center has 750 employees as of Feb 5, 2024.

Mid-Bronx Endoscopy Center - Classification

Industry
  • Professional Service Companies
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Endoscopy
  • Healthcare
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies